AMPA and kainate receptors, along with NMDA receptors, represent different subtypes of glutamate ion channels. AMPA and kainate receptors share a high degree of sequence and structural similarities, and excessive activity of these receptors has been implicated in neurological diseases such as epilepsy. Therefore, blocking detrimental activity of both receptor types could be therapeutically beneficial. Here, we report the use of an in vitro evolution approach involving systematic evolution of ligands by exponential enrichment with a single AMPA receptor target (i.e. GluA1/2R) to isolate RNA aptamers that can potentially inhibit both AMPA and kainate receptors. A full-length or 101-nucleotide (nt) aptamer selectively inhibited GluA1/2R with a K I of ϳ5 M, along with GluA1 and GluA2 AMPA receptor subunits. Of note, its shorter version (55 nt) inhibited both AMPA and kainate receptors. In particular, this shorter aptamer blocked equally potently the activity of both the GluK1 and GluK2 kainate receptors. Using homologous binding and whole-cell recording assays, we found that an RNA aptamer most likely binds to the receptor's regulatory site and inhibits it noncompetitively. Our results suggest the potential of using a single receptor target to develop RNA aptamers with dual activity for effectively blocking both AMPA and kainate receptors.Ionotropic glutamate receptors mediate the majority of excitatory neurotransmission in the mammalian central nervous system (CNS) and are indispensable for brain development and function (1, 2). The ionotropic glutamate receptor family includes three receptor subtypes that can all be activated upon binding of glutamate: ␣-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA), kainate, and N-methyl-D-aspartate (NMDA) receptors (1-3). Compared with NMDA receptors, AMPA and kainate receptors are more alike in both sequence and structure (3, 4). AMPA receptors are expressed post-synaptically and are involved in fast excitatory neurotransmission (1). Kainate receptors are expressed both pre-and post-synaptically, and contribute to excitatory neurotransmission and modulate network excitability by regulating neurotransmitter release (5, 6).AMPA and kainate receptors are widely expressed in the brain. AMPA receptors have four subunits, i.e. GluA1-4. GluA1-3 are enriched in the hippocampus, outer layers of the cortex, olfactory regions, lateral septum, basal ganglia, and amygdala, etc. (7,8). The expression of the GluA4 subunit is low to moderate throughout the CNS, except in the reticular thalamic nuclei and the cerebellum where its level is high (9 -11). Kainate receptors have five subunits, i.e. GluK1-5. At the mRNA level, GluK1 is highly abundant in the neocortex, hypothalamus, and the hindbrain, whereas GluK2 is highly abundant in the cerebellum. GluK3 is widely distributed in the brain.
GluK4 is enriched in the hippocampus (CA3 pyramidal cells).GluK5 is abundant in the neocortex, hippocampus (dentate gyrus and CA2, 3 pyramidal cells), and cerebellum (granule cells) (12,13). At the pro...